148 related articles for article (PubMed ID: 187787)
1. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R
J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787
[TBL] [Abstract][Full Text] [Related]
2. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr capsid antigen.
Henle W; Henie G
J Natl Cancer Inst; 1977 Mar; 58(3):785-6. PubMed ID: 190417
[TBL] [Abstract][Full Text] [Related]
4. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
5. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma.
Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA
Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients.
Biggar RJ; Pandey JP; Henle W; Nkrumah FK; Levine PH
Int J Cancer; 1984 May; 33(5):577-80. PubMed ID: 6327537
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-positive Burkitt's lymphoma in a German woman during pregnancy.
Bornkamm GW; Kaduk B; Kachel G; Schneider U; Fresen KO; Schwanitz G; Hermanek P
Blut; 1980 Mar; 40(3):167-77. PubMed ID: 6244869
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
[TBL] [Abstract][Full Text] [Related]
10. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remission.
Gunvén P; Klein G; Ziegler JL; Magrath IT; Olweny CL; Henle W; Henle G; Svedmyr A; Demissie A
J Natl Cancer Inst; 1978 Jan; 60(1):31-7. PubMed ID: 203706
[TBL] [Abstract][Full Text] [Related]
12. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
[TBL] [Abstract][Full Text] [Related]
13. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies.
Biggar RJ; Nkrumah FK; Henle W; Levine PH
J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
Bardy B; Morinet F; Pérol Y
Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
Gunvén P; Klein G; Clifford P; Singh S
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
[TBL] [Abstract][Full Text] [Related]
17. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to Epstein-Barr viral capsid and early antigens associated with Burkitt's lymphoma and lymphoblastic lymphosarcoma in Israel.
Gotleib-Stematsky T; Ramot B; Vonsover B; Aghai E; Kende G; Ninio M; Modan M
J Natl Cancer Inst; 1976 Apr; 56(4):721-3. PubMed ID: 233958
[TBL] [Abstract][Full Text] [Related]
19. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals.
Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM
Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
Jondal M; Gunven P
Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]